Friday Sessions Evaluations Logo

  • Friday Sessions Evaluations

    Psychedelic Science 2025

  • Instructions

  • Use this form to complete evaluations for each workshop you attended. 

    • Pages are linked in tabs at the top of this page.
    • You can save the form and return to it at any time. When you save the form, you will be prompted to either create an account using your email address or sign up with Google. Alternatively, you can skip creating an account and copy your unique form link. If you create an account, you will receive an email to verify your account and a second email with your form link. Either option will save your progress.
    • Please complete (submit) only one form per person by July 4, 2025.

  • Learner Information

  • Friday, June 20

    • From Ancient Psychedelics To Modern Psychopharmacognosy: Uniting Hellenic Rituals With Advances In Natural Products Chemistry 

    • At the end of the session, the learner will be able to:

      1. Describe the historical and pharmacognostic evolution of psychedelic natural products.

      2. Discuss the role of ergoline alkaloids in the Eleusinian Mysteries and their continuity in contemporary research.

    • Psychedelic Therapy For Military Veterans: A New Paradigm Of Healing The Wounds Of War 

    • At the end of the session, the learner will be able to:

      1. Describe MDMA-AT research protocols taking place with the Dept. of Veterans Affairs.

      2. Contextualize preliminary data from MDMA-AT clinical trials in the VA.

    • Psychedelic-Assisted Couples Therapy: Emerging Evidence From The First Modern Studies 

    • At the end of the session, the learner will be able to:

      1. Describe the therapeutic components of MDMA-assisted couples therapy.

      2. Compare and contrast the use of MDMA-assisted couples therapy for the treatment of PTSD and for general relationship functioning.

    • Safety And Efficacy Of Psilocybin-Assisted Psychotherapy For US Military Veterans With PTSD 

    • At the end of the session, the learner will be able to:

      1. Explain the rationale for psilocybin-assisted therapy (PAT) for veterans with PTSD.

      2. Assess the safety and efficacy of PAT for Veterans with PTSD using the preliminary results from a clinical trial.

    • Veterans’ Attitudes And Beliefs About The Therapeutic Use Of Psychedelic Drugs 

    • At the end of the session, the learner will be able to:

      1. Describe findings from a nationally representative survey of Veterans to understand demographic differences in attitudes, beliefs, and concerns regarding psychedelic-assisted therapies within the context of VHA care.

      2. Discuss the ethical, infrastructural, and cultural considerations influencing the implementation and acceptability of psychedelic-assisted therapies among Veterans, with attention to factors such as "set and setting," equity, and historical underrepresentation.

    • Exploring Differences In Therapeutic Outcomes Between Synthetic Psilocybin And Whole Psilocybe Mushrooms: A Qualitative Study 

    • At the end of the session, the learner will be able to:

      1. Assess the current major limitation of psychedelic research is that it includes primarily monomolecular and synthetic research, which, while useful for precision dosing and scientific study, may not be the most effective method (organic whole plants/fungi may be overall more efficacious).

      2. List the similarities and differences in reports of synthetic psilocybin vs. organic psilocybe mushroom, including subjective effects, differences in texture of experience, and so on.

    • Chronic Illness, Palliative Care And Psychedelics: Patients’ Perspectives 

    • At the end of the session, the learner will be able to:

      1. Describe key clinical components of a community-led psilocybin pilot program for cancer survivors, including participant eligibility criteria, facilitator qualifications, safety protocols, and integration methodologies.

      2. Explaing the preliminary outcomes related to reductions in existential distress, depressive symptoms, and social disconnection among cancer survivors participating in psilocybin-assisted group sessions.

    • Immersive Training Retreats: Opportunities And Challenges Of Experiential Training In The Psychedelic Field 

    • At the end of the session, the learner will be able to:

      1. Describe 3 ways that clinicians can improve competency in psychedelic therapy by attending retreats.

      2. List 2 challenges that leadership teams may face in providing effective experiential training.

    • The Unique Challenges And Potential For Studying Psychedelic-Assisted Therapy For Palestinians And Jews In Israel 

    • At the end of the session, the learner will be able to:

      1. Describe the psychological and clinical implications of implementing psychedelic-assisted therapy in conflict-affected regions, with a specific focus on addressing collective trauma among Israeli Jewish and Arab Palestinian populations.

      2. Assess the potential of MDMA-assisted and other psychedelic therapies to facilitate trauma healing and reconciliation in sociopolitically complex settings, and identify culturally and contextually sensitive adaptations necessary for effective treatment delivery.

    • Critical Evaluation Of Psilocybe Cubensis Mushrooms And Its Clinical Applications At A Unique Jamaican Laboratory 

    • At the end of the session, the learner will be able to:

      1. Describe the safe and standardized P.cubensis product preparation in a GMP certified facility.

      2. Explain how psychohistoriography can target compounds for pychedelic assisted psychotherapy.

    • The Structural Basis And Evolutionary Origins Of Methylation In Psilocybin Biosynthesis 

    • At the end of the session, the learner will be able to:

      1. Describe how magic mushrooms biosynthesize psilocybin, more specifically the last step in the biosynthesis (dimethylation of the amine of norbaeocystin, the psilocybin precursor).

    • Above Ground, Down Under: Reflections From Australia's First Legal Psychedelic Therapy Clinics 

    • At the end of the session, the learner will be able to:

      1. Describe early real-world clinical outcomes from the initial cohort of patients receiving MDMA-assisted therapy at the Empax Centre.

      2. Identify effective strategies for engaging major health funds in the implementation and support of MDMA-assisted therapy.

      3. Discuss practical considerations for developing a learning health system to support the delivery and ongoing improvement of MDMA-assisted treatments.

    • Structural Pharmacology And Therapeutic Potential Of 5-Methoxytryptamines 

    • At the end of the session, the learner will be able to:

      1. Describe the how 5-methoxytrptamines works in the brain and body.

    • Studies Of Ibogaine Therapy And Safety 

    • At the end of the session, the learner will be able to:

      1. Describe the pathological processes involved in TBI and how psychedelic drugs, such as Ibogaine and 5-MeO-DMT, may disrupt these processes.

      2. Describe the effects of Ibogaine and 5-MeO-DMT on TBI symptoms, as well as the challenges of disentangling therapeutic effects in the psychological and physiological domains.

    • Studying The Mechanisms Of Ketamine In Animal Models 

    • At the end of the session, the learner will be able to:

      1. Identify the advantages of dendrimer-based drug delivery systems in targeting CNS disorders such as depression.

      2. Explain the mechanisms through which ketamine and its derivatives exert antidepressant effects in preclinical stress models.

    • 5-MeO-DMT And N,N-DMT: Insight Molecules, Endogenous Psychedelics, And Deconstructing Consciousness 

    • At the end of the session, the learner will be able to:

      1. Discuss the literature surrounding naturally produced (endogenous) N,N-dimethyltryptamine (DMT) in mammals.

      2. Describe the recent advances in this field of study focused on elucidating the physiological role of endogenous DMT and its speculated role in naturally occurring altered states of consciousness.

    • Importance and Validation of Analytical Methods for Botanicals and Botanical Products Containing Psychoactive Compounds. 

    • At the end of the session, the learner will be able to:

      1. Explain validation of analytical methods for botanicals and products containing psychoactive compounds.

      2. Discuss analytical techniques for testing the active components within these matrices, as well as strategies to overcome real-world obstacles associated with their natural variability and complexity.

    • Indigenous Psychedelic-Assisted Therapies: The Challenges And Triumphs Of Advocating For First Nations Inclusion In The Australian PAT Landscape 

    • At the end of the session, the learner will be able to:

      1. Assess the limitations of Western individual-focused models in psychedelic-assisted therapy and contrast them with Indigenous relational and place-based approaches to healing, as presented by members of Indigenous Psychedelic Assisted Therapy (IPAT).

      2. Identify strategies for decolonizing psychedelic-assisted therapy through the integration of Indigenous knowledge systems, with a focus on cultural safety, community-led practice, and inclusive training frameworks.

    • Psychedelic-Assisted Therapy For Personality Disorders 

    • At the end of the session, the learner will be able to:

      1. Explain the pathology of a personality disorder, and why psychedelics might be useful.

      2. Assess the potential utility of psychedelics for personality disorder treatment along with risks.

    • Can Neuroimaging Save Psychedelic Drug Development? 

    • At the end of the session, the learner will be able to:

      1. Explain how functional neuroimaging techniques, particularly fMRI, contribute to understanding the mechanisms of action of psychedelic therapies and support regulatory efforts toward clinical approval.

      2. Assess the role of brain-based biomarkers in addressing placebo effects, validating novel dosing strategies, informing patient stratification, and guiding the development of next-generation psychedelic compounds.

    • Medicine Music Through Time: Honoring Ancient Tradition - Innovating Contemporary Practice 

    • At the end of the session, the learner will be able to:

      1. Recite the definition of the identity- "Two-Spirit".

      2. List the statistics of suicide rates amongst Native American LGBTQ youth.

      3. Describe how to support an expanded perspective of the the therapeutic role of music in clinical and traditional settings.

    • Psyke Panel: Ketamine And Current Controversies 

    • At the end of the session, the learner will be able to:

      1. List the most established mental health applications for therapeutic ketamine treatment, as supported in the existing medical research literature.

      2. Discuss opportunities and challenges (pros and cons) of unsupervised at-home ketamine use as a treatment for depression.

    • Therapeutic Frontiers Of DMT And Ayahuasca: Safety, Depression, And Mental Health 

    • At the end of the session, the learner will be able to:

      1. Describe the outcomes from the Phase 2a clinical trial of DMT with psychotherapy for patients with major depression.

      2. Explain the psychotherapy approach used with patients in the trial.

    • Tracing The Path Of DMT Science In Brazil: Historical Roots And Future Directions 

    • At the end of the session, the learner will be able to:

      1. Describe the neurobiological mechanisms and antidepressant effects of ayahuasca and inhaled N,N-Dimethyltryptamine (DMT) as demonstrated through functional neuroimaging, biomarker analysis, and clinical trial data.

      2. Evaluate the safety, tolerability, and clinical efficacy of DMT-based interventions for treatment-resistant depression, drawing on phase I–IIb trials and open-label studies to inform future psychedelic-assisted treatment protocols.

    • The Potential For Psychedelic-Assisted Therapy In Conflict-Affected Populations: Ukraine And The Balkans 

    • At the end of the session, the learner will be able to:

      1. Analyze the rationale and ethical considerations for investigating psychedelic-assisted therapy as a potential intervention for trauma-related mental health conditions prevalent in conflict-affected populations, using the ongoing research in Ukraine as a specific case study.

      2. Identify the unique challenges and adaptations required for implementing psychedelic-assisted therapy protocols within conflict zones like Ukraine, including considerations for safety, cultural sensitivity, and integration of therapy with existing mental health services in resource-constrained and high-stress environments.

    • Tuning Psychedelics: Progress On Next-Generation Psychedelics Discovery 

    • At the end of the session, the learner will be able to:

      1. Explain key chemical principles—such as acid-base behavior and molecular structure—that influence the properties, formulation, and physiological activity of psychedelic compounds.

      2. Describe how structure-activity relationships, synthetic strategies, and analytical techniques inform the development and scaling of psychedelic substances for research and therapeutic use.

    • Community-Based Psychedelic-Assisted Therapy For Firefighters With PTSD: A Prospective Observational Study 

    • At the end of the session, the learner will be able to:

      1. Assess how integrating Indigenous wisdom and community-based models, such as "Two-Eyed Seeing," into psychedelic-assisted therapy programs can uniquely enhance treatment efficacy and cultural responsiveness for high-risk populations like firefighters with PTSD.

      2. Evaluate preliminary evidence on ketamine-assisted therapy's clinical effectiveness for treatment-resistant PTSD within a community setting, informing best practices for real-world implementation and guiding future policy for diverse patient populations.

    • Reweaving The Web: Family Systems, Psychedelics, And Collective Integration 

    • At the end of the session, the learner will be able to:

      1. Assess the potential of psilocybin-assisted therapy to address intergenerational trauma by integrating family constellations, somatic integration, and emotional intelligence within a family-centered protocol.

      2. Explain how aligning psychedelic therapy with the Evolved Developmental Niche (EDN) framework can restore ancestral family health and enhance bonding, regulation, and resilience in modern family systems.

    • Ayahuasca: Bridging Molecular And Clinical Insights – A Multidisciplinary Panel 

    • At the end of the session, the learner will be able to:

      1. Describe the safety and tolerability of DMT.

      2. Descrive the antidepressant effects of DMT.

    • Bioengineering The Psychedelics: How Ecofriendly, Sustainable, And Low-Cost Bioproduction Can Power The Psychedelic Renaissance 

    • At the end of the session, the learner will be able to:

      1. Identify metabolic pathways of the psychedelic medicines have already been cloned and expressed in different organisms.

      2. Explain how the metabolic pathways were cloned and why.

    • Trauma Under Psychedelic: A Phenomenological Study Of The Survivors Of The 'Nova' Rave: Sense Of Agency, Perception Of Reality, And Their Consequences 

    • At the end of the session, the learner will be able to:

      1. Discuss the complex interplay between acute traumatic stress and psychedelic-induced altered states of consciousness, enabling clinicians to identify potential variations in survivors' sense of agency, perception of reality, and subsequent trauma processing in similar contexts.

      2. Describe considerations for developing psychedelic-informed and culturally sensitive therapeutic interventions for trauma survivors who experienced acute trauma while under the influence of psychedelics, integrating insights from phenomenological research on altered states and their lasting psychological consequences.

    • The Potential For Psychedelic-Assisted Therapy In Conflict-Affected Populations: Ukraine And The Balkans 

    • At the end of the session, the learner will be able to:

      1. Analyze the rationale and ethical considerations for investigating psychedelic-assisted therapy as a potential intervention for trauma-related mental health conditions prevalent in conflict-affected populations, using the ongoing research in Ukraine as a specific case study.

      2. Identify the unique challenges and adaptations required for implementing psychedelic-assisted therapy protocols within conflict zones like Ukraine, including considerations for safety, cultural sensitivity, and integration of therapy with existing mental health services in resource-constrained and high-stress environments.

  • Final Submission

    Click 'Submit' once you have completed this form. You may 'Save' multiple times but only 'sbumit' once.
  • Should be Empty: